Avricore Health Inc
F:8VP1
Avricore Health Inc
F:8VP1
Price:
0.0385
EUR
-3.75%
Market Closed
Market Cap:
€3.8m
Balance Sheet
Balance Sheet Decomposition
Avricore Health Inc
Avricore Health Inc
Balance Sheet Decomposition is not available for
Avricore Health Inc
Avricore Health Inc
Balance Sheet
Avricore Health Inc
Avricore Health Inc
Currency: CAD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Cash Equivalents |
2
|
0
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
2
|
2
|
1
|
0
|
0
|
2
|
1
|
1
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
2
-35%
|
3
+27%
|
1
-59%
|
0
-83%
|
0
+111%
|
2
+418%
|
3
+13%
|
3
-1%
|
2
-9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+45%
|
0
+13%
|
0
-22%
|
1
+114%
|
1
+71%
|
0
-93%
|
1
+616%
|
1
-13%
|
0
-37%
|
|
| Equity | |||||||||||
| Common Stock |
16
|
16
|
19
|
21
|
22
|
22
|
27
|
27
|
27
|
27
|
|
| Retained Earnings |
13
|
14
|
17
|
20
|
22
|
23
|
24
|
25
|
25
|
25
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
2
-41%
|
2
+30%
|
1
-65%
|
0
N/A
|
1
-53%
|
2
N/A
|
2
-11%
|
2
+2%
|
2
-2%
|
|
| Total Liabilities & Equity |
3
N/A
|
2
-35%
|
3
+27%
|
1
-59%
|
0
-83%
|
0
+111%
|
2
+418%
|
3
+13%
|
3
-1%
|
2
-9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14
|
15
|
28
|
40
|
52
|
70
|
98
|
99
|
100
|
101
|
|
Switch to:
Switch to:
See Also
Discover More
